“Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children With Epilepsy”. Brazilian Journal of Pharmaceutical Sciences 59 (maio 8, 2023): e21414. Acessado maio 17, 2024. https://periodicos.usp.br/bjps/article/view/211884.